New guidelines established by the U.S. Food and Drug Administration (FDA) will allow drug manufacturers to tell doctors about unapproved--or "off label"--uses of their medications. The move, which has been opposed by pharmaceutical industry critics, allows drugmakers to distribute medical journal articles that describe unapproved uses for drugs. Experts say the new guidelines could help companies expand the markets for medicines and medical devices.
Read full story >